STOCKHOLM, April 30, 2020 /PRNewswire/ --
- Revenue increased by 19.6% to €238.8m (€199.7m). Organic
revenue grew by 5.8%.
- Operating profit (EBIT) was €6.4m (€11.3m), representing an
operating margin of 2.7% (5.6%).
- Net result amounted to €-2.5m (€6.9m), which represents a net
result margin of -1.0% (3.4%).
- EBITDA increased by 5.6% to €29.0m (€27.5m), corresponding to
an EBITDA margin of 12.2% (13.8%).
- EBITDAaL was €16.8m (€18.5m), corresponding to an EBITDAaL
margin of 7.0% (9.2%).
- Net cash flow from operating activities was €36.5m
(€24.1m).
- Basic/diluted loss per share were €-0.006 (earnings
€0.046).
- Covid-19 pandemic has a significant impact on operating
performance.
REVENUE AND EARNINGS
|
€ millions
(€m)
|
Q1
2020
|
Q1
2019
|
Variance
|
FY
2019
|
|
Revenue
|
238.8
|
199.7
|
20%
|
844.4
|
|
Operating profit
(EBIT)
|
6.4
|
11.3
|
-43%
|
46.5
|
|
Operating profit
margin
|
2.7%
|
5.6%
|
|
5.5%
|
|
Net result
|
-2.5
|
6.9
|
-136%
|
24.7
|
|
Net result
margin
|
-1.0%
|
3.4%
|
|
2.9%
|
|
Basic/diluted
earnings/(loss) per share, €
|
-0.006
|
0.046
|
-113%
|
0.168
|
|
|
|
|
|
|
EBITDA
|
29.0
|
27.5
|
6%
|
120.7
|
|
EBITDA
margin
|
12.2%
|
13.8%
|
|
14.3%
|
|
EBITDAaL
|
16.8
|
18.5
|
-9%
|
80.6
|
|
EBITDAaL
margin
|
7.0%
|
9.2%
|
|
9.5%
|
|
EBITA
|
8.9
|
12.5
|
-29%
|
53.7
|
|
EBITA
margin
|
3.7%
|
6.3%
|
|
6.4%
|
Definition and reconciliation of alternative performance
measures are available
at www.medicover.com/financial-information. As from Q3 2019
margins (including margins of comparative figures) and growth rates
have been calculated based on EUR whole figures instead of figures
rounded in millions.
This is information that Medicover AB is obliged to make public
pursuant to the EU Market Abuse Regulation and the Securities
Markets Act. The information was submitted for publication through
the agency of the contact person set out below at 7.45 (CEST) on
30 April 2020. This interim report
and other information about Medicover is available at
medicover.com.
Contact information
For further information, please contact:
Hanna Bjellquist
Head of Investor Relations
Phone: +46-70-303-32-72
E-mail: hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and
diagnostic services company and was founded in 1995. Medicover
operates a large number of ambulatory clinics, hospitals,
specialty-care facilities and laboratories and the largest markets
are Poland and Germany. In 2019, Medicover had revenue around
€844 million and 28,800 employees. For more information, go to
www.medicover.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/medicover/r/interim-report-january-march-2020,c3101087
The following files are available for download:
|
https://mb.cision.com/Main/15662/3101087/1239343.pdf
|
Interim report
January-March 2020
|
